Cardiac decompression sickness after hypobaric chamber training: case report of a coronary gas embolism.
Article: Incidence of decompression sickness in hypoxia training with and without 30-min O2 prebreathe.[show abstract] [hide abstract]
ABSTRACT: All naval aviators, navigators, and aircrewmen are required to participate in hypoxia familiarization training. This training is performed in a hypobaric chamber and is considered high risk due to the potential for barotrauma and/or decompression sickness (DCS). Prior analysis of the DCS in U.S. Navy hypobaric chambers revealed a significantly higher incidence among inside observers (IOs) compared with students. In response to these reports, all IOs are required to denitrogenate by breathing 100% oxygen for 30 min prior to altitude exposure (prebreathing). Although the Army, Navy, and Air Force prebreathe for 30 min prior to most hypobaric training exposures, there have been no reports validating the efficacy of this measure. This study examined the incidence of altitude DCS during training exposures to simulated altitudes of 25,000 ft (25k) and 35,000 ft (35k) in IOs and students, some of whom prebreathed and some of whom did not. Exposures and DCS cases for a period of 9 yr were tabulated from training reports maintained at the Naval Operational Medicine Institute in Pensacola, FL. Chi-square or Fisher's Exact test was used to compare the data sets and p < or = 0.05 was considered significant. The overall DCS incidence for students and IOs for all chamber profiles was 0.25%. The incidence for 25k was 0.29% for students who did not prebreathe and 0.15% for IOs who did (p = 0.10). Within the student group there was a 0.44% DCS incidence for 25k with no prebreathe and a 0.17% DCS incidence for 35k with prebreathe (p = 0.004). A 30-min prebreathe prior to altitude exposure appears to contribute to a reduction in the risk of DCS during hypobaric chamber training.Aviation Space and Environmental Medicine 01/2003; 74(1):56-61. · 0.88 Impact Factor
[show abstract] [hide abstract]
ABSTRACT: With the potential for higher aircraft and cabin altitudes, the way in which altitude decompression sickness (DCS) presents continues to be of interest. The majority of previous papers on the symptomatology of DCS are retrospective reviews of patients treated hours or days post-exposure. The initial presentation while still at altitude is the form of DCS that aircrew must be able to recognize in order to respond correctly. This paper reports the initial manifestations of DCS that occurred during a series of prospective hypobaric chamber studies. These studies had been specifically designed to investigate DCS. This paper presents a prospective analysis of DCS symptoms from 447 subjects, recorded over an 11-yr period at the Armstrong Laboratory (AL), and is an attempt to provide an accurate representation of the initial presentation of altitude DCS. Of the 447 cases, 83.2% had musculoskeletal involvement, 2.7% had chokes, 2.2% skin manifestations, 10.8% paresthesia, and 0.5% frank neurological features. The most common presenting feature was musculoskeletal, with knee pain predominating (occurring in 70% of these cases). A very low incidence of neurological features was seen in the AL database, which was in contrast to data from many other sources. Reasons for this difference may include the use of preoxygenation and the policy of prompt recompression upon symptom development at AL. There is also the possibility that individuals in the training and operational environments are more likely to report frank neurological involvement than other forms of DCS.Aviation Space and Environmental Medicine 11/1996; 67(10):983-9. · 0.88 Impact Factor
[show abstract] [hide abstract]
ABSTRACT: Based on a literature search, an overview is presented of the pathophysiology of venous and arterial gas embolism in the experimental and clinical environment, as well as the relevance and aims of diagnostics and treatment of gas embolism. The review starts with a few historical observations and then addresses venous air embolism by discussing pulmonary vascular filtration, entrapment, and the clinical occurrence of venous air emboli. The section on arterial gas embolism deals with the main mechanisms involved, coronary and cerebral air embolism (CAE), and the effects of bubbles on the blood-brain barrier. The diagnosis of CAE uses various techniques including ultrasound, perioperative monitoring, computed tomography, brain magnetic resonance imaging and other modalities. The section on therapy starts by addressing the primary treatment goals and the roles of adequate oxygenation and ventilation. Then the rationale for hyperbaric oxygen as a therapy for CAE based on its physiological mode of action is discussed, as well as some aspects of adjuvant drug therapy. A few animal studies are presented, which emphasize the importance of the timing of therapy, and the outcome of patients with air embolism (including clinical patients, divers and submariners) is described.Clinical physiology and functional imaging 10/2003; 23(5):237-46. · 1.21 Impact Factor
Cardiac Decompression Sickness After Hypobaric Chamber
Training: Case Report of A Coronary Gas Embolism
Alçak Bas›nç Çemberi E¤itimi Sonras›nda Geliflen Kardiyak Dekompresyon Hastal›¤›:
Koroner Gaz Embolismi Olgusu Takdimi
Cengiz Öztürk, MD, Ahmet fien*, MD, Ahmet Ak›n*, MD, Atilla ‹yisoy**MD,
600 Bed Air Force Military Hospital, Eskiflehir, *Department of Aerospace Medicine, Gulhane Military Academy, Eskiflehir
**Department of Cardiology, Gulhane Military Academy, Ankara, Turkey
Air embolism is an uncommon but potentially catastrophic
event, which occurs as a consequence of the entry of air into
the vasculature. Surgery, instrumentation of the central veno-
us system, positive pressure ventilation, trauma and decomp-
ression are the most common causes of air embolism. De-
compression sickness is an illness caused by reduced pressu-
re on the body that results in formation of bubbles of an inert
gas and specific related symptoms. Decompression sickness
is still a risk for both aviators and divers (1). Here we report a
cardiac decompression sickness case due to air embolism.
A 22-year-old male pilot candidate was evaluated for sud-
den dyspnoea and chest pain after hypobaric chamber tra-
ining (Fig. 1). This training is given in order to simulate high al-
titude hypoxia. The pilot candidate had periodic medical exa-
mination, which revealed to be completely normal prior to
hypobaric chamber training. He was exposed to hypobaric en-
vironment for about one hour (total time for ascending and
descending) staying at the maximum 35,000 feet atmospheric
pressure for about 15 min. Two hours after the training he was
transferred to emergency department because of chest pain
at rest typical of myocardial infarction (MI). On admission, he
was anxious with profuse sweating. He was normotensive,
nondiabetic, nonsmoker and had no family history of coronary
artery disease. Blood pressure was 140/90 mmHg, heart rate
was 90 beats per minute. Physical examination was unremar-
kable. His electrocardiogram (ECG) revealed ST segment ele-
vation in the derivations DII, DIII, AVF, V5, V6; ST segment dep-
ression in DI and aVL (Fig. 2). Considered as an acute MI case
due to decompression cardiac sickness (DCS), he was imme-
diately taken into hyperbaric chamber (Fig. 3), because it is a
general rule for decompression sickness that diagnostic pro-
cedures must not cause a delay in the specific treatment. The
patient denied any risk factors known for DCS such as SCUBA
diving, strenuous exercise or Rapid Decompression (cabin
depressurization) in the previous days.
He was given hyperbaric oxygen therapy (HBOT) accor-
ding to US-Navy Treat: Table 6 (2), aggressive hydration and
100% oxygen breathing with a tight fitting mask (3), resulting in
rapid resolution of the symptoms at 15th minute of HBOT. Af-
ter HBOT ECG disclosed changes compatible with an acute in-
ferolateral MI (1 mm ST segment elevations and significant
decrease in R amplitude (poor R wave progression) in DII, DI-
II, aVF, V5, V6; 0.5 mm ST segment depression and increased
T amplitude in V1 and V2 derivations) (Fig. 4). On admission to
coronary care unit, the patient was stabilised and free of
chest discomfort, he was then monitored. He experienced
ventricular extrasystoles and rare couplet forms suggestive of
reperfusion. Chest X-ray, complete blood count and blood
chemistry (including lipid profile) other than cardiac enzymes
were within normal limits. Since he was considered as de-
compression sickness and responded to HBOT dramatically,
no additional medication, including antiaggregant, anticoagu-
lant, thrombolytic or antiischemic drugs were administered.
Creatine phosphokinase, creatine phosphokinase MB fraction
and aspartate aminotransferase enzymes presented early pe-
ak at 24th hour and early wash-out compatible with early re-
perfusion. In serial ECGs, ST segment elevations and decre-
ased R amplitude in lateral derivations regressed and ST seg-
ment elevations in inferior derivations returned to baseline. He
was discharged on the 7th day of hospitalisation having no ot-
her symptoms and complications.
Two months after discharge, transthoracic echocardiog-
raphy revealed inferobasal hypokinesia and mild mitral insuf-
ficiency. Ejection fraction was slightly below normal limits. A
symptom-limited exercise ECG performed up to Bruce stage V,
showed no evidence of myocardial ischaemia and hyperventi-
lation test was also normal. Myocardial perfusion scintigraphy
with Thallium 201 was normal. Coronary angiography disclo-
sed neither lesion nor coronary anomaly. Left ventriculog-
raphy revealed mild hypokinesia in posterobasal segments.
Three months after the episode he was allowed for full flight
Address for Correspondence: Dr. Cengiz Öztürk, 600 Yatakl› Hava Hastanesi 26020, Eskiflehir, Tel: 0 222 2204530/4170, e-mail: firstname.lastname@example.org
Olgu Sunumu Case Report
duties. The rationale for this decision was the intact structure
of coronary arteries. He has been in active duty as a fighter pi-
lot for 3 years without any cardiac event.
Decompression sickness may cause potentially fatal out-
comes by means of gas embolism. Although it is mainly obser-
ved in divers after rapid ascent, it may also occur in aviators
during high altitude flights or simulated training conditions.
Decompression sickness, also known as “bends”, was origi-
nally described as "caisson disease" when it was first recog-
nised in 1843 among tunnel workers following return from the
compressed environment of the caissons to the normal at-
mospheric pressure (2).
Under higher atmospheric pressures the tissues become
loaded with increased quantities of oxygen and nitrogen. As
atmospheric pressure decreases, ie. while divers ascend to
surface or aviators climb up to higher altitudes, the sum of the
gas tensions in the tissue may exceed the ambient partial
pressure of the gas and lead to the liberation of free gas from
the tissues in the form of bubbles. The liberated gas bubbles
can alter organ function by blocking vessels, rupturing or
compressing tissue, or activating clotting and inflammatory
Overall incidence of DCS occurring after hypobaric cham-
ber training was found about 0.19-0.32 (4). Among these cases
incidence of cardiac DCS cases, which are characterized with
coronary gas embolus or cardiovascular collapse is 0.2% (5).
However a detailed description of such a case was not ava-
ilable in the medical literature.
Approximately 75% of patients with decompression sick-
ness develop symptoms within 1 hour and 90 percent within 12
hours of exposure; only a small number of the cases become
symptomatic after 24 hours. Symptoms differ according to or-
gan systems involved (6). Although it is suspected that there is
a tendency for a person who develops DCS under given con-
ditions to again develop DCS under similar circumstances, it
has not been proven yet. It is also interesting that bubble for-
mation may not always result in symptoms or embolus (7).
Since sudden loss of cabin pressure is a major risk for
DCS, pilots and candidates who take this type of training in
Figure 1. Hypobaric chamber
Figure 3. Hyperbaric oxygen chamber
Figure 4. Patient’s electrocardiogram after hyperbaric oxygen therapy
Figure 2. Patient’s initial electrocardiogram on admission.
Anadolu Kardiyol Derg
Öztürk et al.
Cardiac Decompression Sickness257
hypobaric chamber must adequately be informed of these
dangers. Sudden cabin explosion of airline transport planes at
high altitudes generally would not pose a serious risk because
of the rapid descent, however signs or symptoms of MI occur-
ring after such an event must be evaluated carefully.
Atherosclerosis of coronary arteries resulting in MI is still
one of the most important causes of morbidity and mortality.
Besides atherosclerosis, gas and air emboli are among rare
causes of MI. As little as 0.5 ml of air in the coronary circula-
tion can lead to dysrhythmias, myocardial infarction, and/or
cardiac arrest. Gas emboli are encountered in divers and avi-
ators due to decompression sickness; whereas the most com-
mon causes of air emboli in daily clinical practice are surgery
(especially open heart surgery), trauma, central venous cat-
heterisation, barotrauma due to positive pressure ventilation,
cardiac catheterisation and ruptured angioplasty balloon (8).
Therapeutic approach in management of MI differs greatly
in case of gas or air emboli; therefore it must be kept in mind
to prevent potentially fatal outcomes in patients with compa-
The primary aims of the treatment are identification of the
source of air or gas, prevention of further embolisation, remo-
val of embolised gas and restoration of circulation. Nitrogen
washout by means of high flow supplemental oxygen with a
tight fitting mask, supine positioning, supportive measures in
addition to HBOT are the main therapeutic strategies. Hyper-
baric oxygen therapy reduces air bubble size, accelerates nit-
rogen resorption, and increases the oxygen content of arteri-
al blood, potentially ameliorating ischaemia. Although prompt
initiation of HBOT is preferred, it may improve outcome even if
delayed up to 30 hours (9).
Acute MI in our patient was considered to be due to gas
embolus. Being evaluated medically normal prior to hypobaric
chamber training, absence of cardiac risk factors and underl-
ying systemic disease, development of symptoms two hours
after decompression and dramatic response to recompressi-
on were the key factors in diagnosis. Time-gap between de-
compression and onset of the symptoms is due to circulating
silent bubbles before lodging.
Clinical causes of air/gas emboli such as open heart sur-
gery, trauma, pulmonary barotrauma, cardiac catheterisation
and ruptured angioplasty balloon can be seen in daily practi-
ce. In such cases HBOT will be helpful as well. In order to bet-
ter understand the mechanisms acting in the pathological pro-
cess of Cardiac Decompression Sickness, controlled experi-
mental studies should be planned.
1.MacMillan AJF. Decompression sickness. In: Ernsting J, King P,
editors. Aviation Medicine-I. London: Butterworths; 1988. p.19-26.
Heimbach RD, Sheffield PJ. Decompression sickness and pulmo-
nary overpressure accidents. In: DeHart RL, editor. Fundamen-
tals of Aerospace Medicine. 2nd ed. Baltimore: Williams and Wil-
kins; 1996. p.136-9.
Dutka AJ. Clinical findings in decompression illness : a proposed
terminology. In: Moon RE, Sheffield PJ, editors. Treatment of De-
compression Illness. Kensington, MD: Undersea and Hyperbaric
Medical Society; 1996. p.1-9.
Rice GM, Vacchiano CA, Moore JL Jr, Anderson DW. Incidence
of decompression sickness in hypoxia training with and without
30-min O2 prebreathe. Aviat Space Environ Med 2003; 74: 56-61.
Ryles MT, Pilmanis AA. The initial signs and symptoms of altitu-
de decompression sickness. Aviat Space Environ Med 1996; 67:
Elliott DH, Moon RE. Manifestations of the decompression disor-
ders. In Bennet PB, Elliott DH, editors. The Physiology and Medi-
cine of Diving, 4th ed. Philadelphia: WB Saunders; 1993. p.481-
Balldin UI, Borgström P. Intracardiac bubbles during decompres-
sion to altitude in relation to decompression sickness in man.
Aviat Space Environ Med 1976; 47: 113-6.
van Hulst RA, Klein J, Lachmann B. Gas embolism: pathophysi-
ology and treatment. Clin Physiol Funct Imaging 2003; 23: 237-46.
Moon RE, Sheffield PJ. Guidelines for the treatment of decomp-
ression illness. Aviat Space Environ Med 1997; 68: 234-43.
20. YY’da Birecik’ten bir enstantane.
Anadolu Kardiyol Derg
Öztürk et al.
Cardiac Decompression Sickness